A nurse is caring for a client who has severe pre-eclampsia and is receiving hydralazine IV.

Which of the following adverse effects should the nurse monitor for?

A nurse is monitoring a client with severe pre-eclampsia who is receiving magnesium sulfate infusion.

What is the antidote for magnesium sulfate toxicity?

A nurse is caring for a client with eclampsia who is receiving magnesium sulfate and has a magnesium level of 10 mg/dL.

Which of the following medications should the nurse have available as an antidote?

(select all that apply) A nurse is reviewing the laboratory results of a client with eclampsia who is receiving magnesium sulfate.

Which of the following values should the nurse report to the provider? (Select all that apply.)

A nurse is evaluating the effectiveness of magnesium sulfate therapy for a client who has eclampsia.

Which of the following outcomes indicates that the therapy is successful?

A nurse is evaluating the fetal status of a client who has preeclampsia and is receiving magnesium sulfate.

Which of the following findings should the nurse report to the provider as a sign of fetal compromise?

A nurse is monitoring a client with severe pre-eclampsia who is receiving magnesium sulfate intravenously.

Which of the following assessments is the most important for the nurse to perform?

A nurse is caring for a client with eclampsia who is having a tonic-clonic seizure.

Which action should the nurse take first?

A nurse is evaluating the effectiveness of magnesium sulfate therapy for a client with eclampsia.

What clinical indicator would suggest that the therapy is successful?

A nurse is providing discharge instructions to a client who had preeclampsia and delivered her baby 2 days ago.

Which of the following instructions should the nurse include?

A nurse is providing discharge teaching to a client who had pre-eclampsia and delivered a healthy newborn.

Which of the following statements by the client indicates an understanding of the teaching?